Analysis of the Immunochemistry Market in Malaysia
The Malaysian immunochemistry market was worth $ million in 2014 and the market is expected to grow at CAGR of % from 2014–2020.
The immunochemistry market is dominated by three multinational companies: Roche, Siemens, and Beckman Coulter, that together hold % of the market. The remaining market is captured by companies like Becton Dickenson, Abbott, Sysmex, and some Chinese companies.
The demand for immunochemistry equipment and reagents mainly comes from public and private hospitals where the volume of tests is high. Central laboratories and research institutes form a small segment of the market. The market has high brand loyalty towards Multinational Companies (MNCs) and end users are unlikely to switch to other brands.
While public hospitals prefer purchases through a tendering system, most procurements are done annually; private hospitals and central laboratories buy equipment purely on a need basis. In public hospitals, pricing is the key differentiator for selection. Most public hospitals prefer low-cost equipment.
Electronic Access - Site License Fulfilled By Publisher
Electronic Access - Global site License Fulfilled By Publisher